Toggle navigation
Home
Search
Services
Blog
Contact
About
Treatment of Preserved Systolic Function with an Aldosterone Antagonist
Search grants from
Share this grant:
:
:
Abstract
Funding
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
A Quantitative Epigenetic Test for Guiding Smoking Cessation Therapy
Gene Therapy for Retinitis Pigmentosa
Startle Gating and Locomotion in D2-Family Knockout Mice
Development of Gastric Hcl Secretion
Inhibition of Human Cytochrome P450 1A2 by Furafylline
Recently added grants:
Cholinergic contribution to pupil-linked arousal
The effects of BTNL2 on experimental autoimmune encephalomyelitis
Transitions in Care for Older Nursing Home Residents with Dementia from Entry to Death: a retrospective cohort study, 2014-2019
Patient-Specific Strategies for Capsular Repair Following Shoulder Dislocations
Transcriptomic and epigenomic landscape of neurodegenerative disease models
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research and Development Contracts (N01)
Project #
N01HC45207-10-0-1
Application #
7569624
Study Section
Project Start
2004-08-01
Project End
2012-07-31
Budget Start
Budget End
Support Year
Fiscal Year
2007
Total Cost
Indirect Cost
Related projects
NIH 2008
N01 HL
Treatment of Preserved Systolic Function with an Aldosterone Antagonist
/ New England Research Institute
$7,912,414
NIH 2007
N01 HL
Aldosterone Antagonists for the Treatment of Heart Failure with Preserved Systol
McKinlay, Sonja M. /
$2,217,724
NIH 2007
N01 HL
Treatment of Preserved Systolic Function with an Aldosterone Antagonist
/
NIH 2007
N01 HL
/
Comments
Be the first to comment on this grant